| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |